Federal Data HubHRSA 340B · JSON

CENTER FOR COMPREHENSIVE CARE & DIAGNOSIS OF INHERITED BLOOD DISORDERS (CIBD)

340B ID HM92668

ParticipatingHemophilia Treatment Center

CENTER FOR COMPREHENSIVE CARE & DIAGNOSIS OF INHERITED BLOOD DISORDERS (CIBD) is a Hemophilia Treatment Center enrolled in the federal 340B Drug Pricing Program in Orange, CA. The program lets qualifying providers buy outpatient drugs at deep federal discounts. This entity reports 11 contract-pharmacy arrangement(s) (7 currently active) — the third-party pharmacies that dispense its 340B-discounted drugs.

Contract pharmacies (11)

PharmacyLocationBeginTerminatedPharmacy ID
ACCREDO HEALTH GROUP INCCORONA, CA2025-10-0181045
ACCREDO HEALTH GROUP INCWARRENDALE, PA2025-10-0123041
CRESCENT HEALTHCARE INCSANTA FE SPRINGS, CA2016-04-012019-10-0478232
CRESCENT HEALTHCARE, INC.SANTA FE SPRINGS, CA2019-10-03123913
OPTION CARECHICO, CA2019-10-052021-04-12124359
OPTION CARESUN VALLEY, CA2021-07-01123905
OPTION CARE ENTERPRISES, INC.CHICO, CA2016-04-012019-10-0783667
OPTUM INFUSION SERVICES 401, LLCSACRAMENTO, CA2023-01-0191420
OPTUM INFUSION SERVICES 550, LLCCARLSBAD, CA2023-01-01126532
RED CHIP OF NEVADAIRVINE, CA2020-10-0195592
Red Chip of NevadaIrvine, CA2020-10-012025-01-0799860

Click a Pharmacy ID to see every other 340B entity using that same pharmacy.

About this data

The 340B Drug Pricing Program (Public Health Service Act §340B) requires drug manufacturers to sell outpatient drugs to enrolled "covered entities" — disproportionate-share hospitals, federally qualified health centers, and specialized clinics — at significant discounts. Covered entities increasingly contract with third-party "contract pharmacies" to dispense these drugs, a practice that has grown explosively and drawn scrutiny over how the discounts are used. This page mirrors HRSA's Office of Pharmacy Affairs (OPAIS) public registry.

Source: HRSA OPAIS. License: CC0 1.0. Snapshot 2026-06-25.